This preclinical in vitro study investigated the effects of a Boletus edulis (porcini) mushroom extract on antibiotic-induced dysbiotic microbiota.
Life · 8 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical in vitro study investigated the effects of a Boletus edulis (porcini) mushroom extract on antibiotic-induced dysbiotic microbiota.
This study used an in vitro model to evaluate the effect of a Boletus edulis extract on antibiotic-induced dysbiotic gut microbiota. The researchers analyzed the extract's impact on microbial diversity, metabolomic patterns (including short-chain fatty acids), and cytokine responses. The authors suggest these effects indicate a synergistic restoration of microbiota balance and a potential anti-inflammatory role. Limitations include the in vitro nature of the study, which limits direct extrapolation to human physiology, and the mechanisms remain poorly understood.